Annual report pursuant to Section 13 and 15(d)

Discontinued Operations (Amounts Included in Consolidated Statements of Operations) (Details)

v2.4.0.6
Discontinued Operations (Amounts Included in Consolidated Statements of Operations) (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net sales $ 78,738 $ 597,729 $ 617,392
Research and development 16,890,482 15,154,365 8,941,046
Selling, general and administrative 11,177,559 9,547,779 4,353,136
Total operating expenses 28,068,041 24,702,144 13,294,182
Other expense, net (1,167,901) (943,161) (43,567,204)
Income taxes    (7,880,143) (2,134,903)
Income from discontinued operations    3,329,534 4,144,223
GDS Business and Cardiosonix Subsidiary [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net sales   7,684,689 10,140,476
Cost of goods sold   2,324,427 3,230,575
Gross profit   5,360,262 6,909,901
Research and development   564,194 371,794
Selling, general and administrative   308,220 258,452
Total operating expenses   872,414 630,246
Other expense, net   (1,084) (529)
Income taxes   (1,157,230) (2,134,903)
Income from discontinued operations   $ 3,329,534 $ 4,144,223